Search Results1-18 of  18

  • Jinnouchi Hideaki ID: 9000007101568

    Articles in CiNii:1

    • Studies on the Mechanism of Synergistic Action with Synergisidin and Imidazole Antimycotics （1981）
  • Jinnouchi Hideaki ID: 9000356551195

    Articles in CiNii:1

    • Insulin degludec in a simple or stepwise titration algorithm in a Japanese population of patients with type 2 diabetes : a randomized, 26-week, treat-to-target trial （2017）
  • JINNOUCHI HIDEAKI ID: 9000255926975

    Laboratory of Nutrition and Physiological Chemistry, College of Agriculture and Veterinary Medicine, Nihon University, Tokyo, Japan （1981 from CiNii）

    Articles in CiNii:1

    • STUDIES ON THE MECHANISM OF SYNERGISTIC ACTION WITH SYNERGISIDIN AND IMIDAZOLE ANTIMYCOTICS （1981）
  • JINNOUCHI HIDEAKI ID: 9000256772971

    Laboratory of Nutrition and Physiological Chemistry, College of Agriculture and Veterinary Medicine, Nihon University （1980 from CiNii）

    Articles in CiNii:1

    • STUDIES ON TERREIC ACID （1980）
  • JINNOUCHI HIDEAKI ID: 9000256773376

    Laboratory of Nutrition and Physiological Chemistry, College of Agriculture and Veterinary Medicine, Nihon University （1981 from CiNii）

    Articles in CiNii:1

    • STUDIES ON SYNERGISIDIN （1981）
  • JINNOUCHI Hideaki ID: 9000006744036

    Jinnouchi Clinic, Diabetes Care Center （2012 from CiNii）

    Articles in CiNii:4

    • Aspirin Reduces Cerebrovascular Events in Type 2 Diabetic Patients With Poorly Controlled Blood Pressure : Subanalysis From the JPAD Trial （2012）
    • OJ-087 Increased Cholesterol Absorption in Japanese Patients with Type-2 Diabetes Mellitus Treated with Statins(Lipid disorders(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) （2008）
    • 5 The Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD)(Late Breaking Clinical Trials I,The 73rd Annual Scientific Meeting of The Japanese Circulation Society) （2009）
  • JINNOUCHI Hideaki ID: 9000022204299

    Division of Food Science, The National Institute of Nutrition|Research and Development Department, Sawai Pharmaceutical Co., Ltd., （1984 from CiNii）

    Articles in CiNii:1

    • Differential effects of dietary eicosapentaenoic and docosahexaenoic fatty acids on lowering of triglyceride and cholesterol levels in the serum of rats on hypercholesterolemic diet. （1984）
  • JINNOUCHI Hideaki ID: 9000022204537

    Laboratory of Nutrition and Physiological Chemistry, College of Agriculture and Veterinary Medicine, Nihon University （1976 from CiNii）

    Articles in CiNii:1

    • Effects of tetraacetyl-bis-dehydroascorbic acid, a derivative of ascorbic acid, on ehrlich cells and hela cells (human carcinoma cells). （1976）
  • JINNOUCHI Hideaki ID: 9000256911580

    Department of Preventive Cardiology, Kumamoto University Hospital （2013 from CiNii）

    Articles in CiNii:1

    • Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes （2013）
  • JINNOUCHI Hideaki ID: 9000263055179

    Jinnouchi Hospital （2013 from CiNii）

    Articles in CiNii:1

    • Successful Diet and Exercise Therapy as Evaluated on Self-Assessment Score Significantly Improves Endothelial Function in Metabolic Syndrome Patients （2013）
  • JINNOUCHI Hideaki ID: 9000265555992

    Jinnouchi Hospital （2013 from CiNii）

    Articles in CiNii:1

    • Effect of Low-Dose Aspirin on Primary Prevention of Cardiovascular Events in Japanese Diabetic Patients at High Risk （2013）
  • Jinnouchi Hideaki ID: 9000257811520

    Jinnouchi Hospital （2013 from CiNii）

    Articles in CiNii:1

    • Rationale, Design, and Baseline Characteristics of a Trial for the Prevention of Diabetic Atherosclerosis Using a DPP-4 Inhibitor: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) （2013）
  • Jinnouchi Hideaki ID: 9000261653007

    Jinnouchi Hospital （2014 from CiNii）

    Articles in CiNii:1

    • Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes:– Lipid-Lowering With Highly Potent Statins in Hyperlipidemia With Type 2 Diabetes Patients (LISTEN) Study – （2014）
  • Jinnouchi Hideaki ID: 9000314067171

    Diabetes Care Center, Jinnouchi Hospital|Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital （2016 from CiNii）

    Articles in CiNii:1

    • Low-Normal Serum Sodium and Heart Failure-Related Events in Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction （2016）
  • Jinnouchi Hideaki ID: 9000376945845

    Diabetes Care Center, Jinnouchi Hospital|Cardiovascular Division, Diabetes Care Center, Jinnouchi Hospital|Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital （2017 from CiNii）

    Articles in CiNii:1

    • Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes （2017）
  • Jinnouchi Hideaki ID: 9000386335811

    Diabetes Care Center, Jinnouchi Hospital, Japan|Cardiovascular Division, Diabetes Care Center, Jinnouchi Hospital, Japan|Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital, Japan （2018 from CiNii）

    Articles in CiNii:1

    • The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus （2018）
  • Jinnouchi Hideaki ID: 9000396104167

    Diabetes Care Center, Jinnouchi Hospital|Cardiovascular Division, Diabetes Care Center, Jinnouchi Hospital|Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital （2018 from CiNii）

    Articles in CiNii:1

    • Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes （2018）
  • Jinnouchi Hideaki ID: 9000397686567

    Diabetes Care Center, Jinnouchi Hospital, Japan|Cardiovascular Division, Diabetes Care Center, Jinnouchi Hospital, Japan|Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital, Japan （2018 from CiNii）

    Articles in CiNii:1

    • The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus （2018）
Page Top